Prevalence and molecular characteristics of drug-resistant mycobacterium tuberculosis in hunan, china

Antimicrobial Agents and Chemotherapy

Volumn 58, Issue 6, 2014, Pages 3475-3480

  Zhao, Li Li ^a,b   Chen, Yan ^a,c   Chen, Zhong Nan ^d   Liu, Hai Can ^a,b   Hu, Pei Lei ^d   Sun, Qing ^a,c   Zhao, Xiu Qin ^a,b   Jiang, Yi ^a,b   Li, Gui Lian ^a,b   Tan, Yun Hong ^d   Wan, Kang Lin ^a  

^a CHINESE CENTER FOR DISEASE CONTROL AND PREVENTION   (China)

^b Collaborative Innovation Center for Diagnosis and Treatment of Infectious ^*  (China)

^c UNIVERSITY OF SOUTH CHINA   (China)

^d Hunan Provincial Chest Hospital Tuberculosis Control Institution of Hunan Province   (China)

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; BACTERIAL PROTEIN; CAPREOMYCIN; DNA TOPOISOMERASE (ATP HYDROLYSING) A; DNA TOPOISOMERASE (ATP HYDROLYSING) B; EIS PROTEIN; EMBB PROTEIN; ETHAMBUTOL; INHA PROTEIN; ISONIAZID; KANAMYCIN; KATG PROTEIN; NUCLEOTIDE; OFLOXACIN; PNCA PROTEIN; PYRAZINAMIDE; RIFAMPICIN; RNA POLYMERASE BETA SUBUNIT; RPSL PROTEIN; RRS PROTEIN; STREPTOMYCIN; TLYA PROTEIN; UNCLASSIFIED DRUG; BACTERIAL DNA; TUBERCULOSTATIC AGENT;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; CHINA; CLINICAL ARTICLE; CODON; DNA SEQUENCE; DRUG RESISTANT TUBERCULOSIS; FEMALE; GENOTYPE; HUMAN; MALE; MYCOBACTERIUM BOVIS BCG; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PRIORITY JOURNAL; ADOLESCENT; AGED; ANTIBIOTIC RESISTANCE; CHEMISTRY; DEMOGRAPHY; DRUG EFFECTS; GENETICS; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; MICROBIOLOGY; MIDDLE AGED; MUTATION; TUBERCULOSIS, MULTIDRUG-RESISTANT; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTITUBERCULAR AGENTS; CHINA; DEMOGRAPHY; DNA, BACTERIAL; DRUG RESISTANCE, BACTERIAL; FEMALE; GENOTYPE; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MUTATION; MYCOBACTERIUM TUBERCULOSIS; SEQUENCE ANALYSIS, DNA; TUBERCULOSIS, MULTIDRUG-RESISTANT; YOUNG ADULT;

EID: 84901246268     PISSN: 00664804     EISSN: 10986596     Source Type: Journal    
DOI: 10.1128/AAC.02426-14     Document Type: Article

References (35)

1. Gandhi NR, Nunn P, Dheda K, Schaaf HS, Zignol M, van Soolingen D, Jensen P, Bayona J. 2010. Multidrug-resistant and extensively drugresistant tuberculosis: a threat to global control of tuberculosis. Lancet 375:1830-1843. http://dx.doi.org/10.1016/S0140-6736(10)60410-2.
2. Zhao Y, Xu S, Wang L, Chin DP, Wang S, Jiang G, Xia H, Zhou Y, Li Q, Ou X, Pang Y, Song Y, Zhao B, Zhang H, He G, Guo J, Wang Y. 2012. National survey of drug-resistant tuberculosis in China. N. Engl. J. Med. 366:2161-2170. http://dx.doi.org/10.1056/NEJMoa1108789.
3. He GX, Zhao YL, Jiang GL, Liu YH, Xia H, Wang SF, Wang LX, Borgdorff MW, van der Werf MJ, van den Hof S. 2008. Prevalence of tuberculosis drug resistance in 10 provinces of China. BMC Infect. Dis. 8:166. http://dx.doi.org/10.1186/ 1471-2334-8-166.
4. Afanas'ev MV, Ikryannikova LN, Il'ina EN, Sidorenko SV, Kuz'min AV, Larionova EE, Smirnova TG, Chernousova LN, Kamaev EY, Skorniakov SN, Kinsht VN, Cherednichenko AG, Govorun VM. 2007. Molecular characteristics of rifampicin-And isoniazid-resistant Mycobacterium tuberculosis isolates from the Russian Federation. J. Antimicrob. Chemother. 59:1057-1064. http://dx.doi.org/10.1093/ jac/dkm086.
5. Filliol I, Driscoll JR, Van Soolingen D, Kreiswirth BN, Kremer K, Valetudie G, Anh DD, Barlow R, Banerjee D, Bifani PJ, Brudey K, Cataldi A, Cooksey RC, Cousins DV, Dale JW, Dellagostin OA, Drobniewski F, Engelmann G, Ferdinand S, Gascoyne-Binzi D, Gordon M, Gutierrez MC, Haas WH, Heersma H, Kallenius G, Kassa-Kelembho E, Koivula T, Ly HM, Makristathis A, Mammina C, Martin G, Mostrom P, Mokrousov I, Narbonne V, Narvskaya O, Nastasi A, Niobe-Eyangoh SN, Pape JW, Rasolofo-Razanamparany V, Ridell M, Rossetti ML, Stauffer F, Suffys PN, Takiff H, Texier-Maugein J, Vincent V, De Waard JH, Sola C, Rastogi N. 2002. Global distribution of Mycobacterium tuberculosis spoligotypes. Emerg. Infect. Dis. 8:1347-1349. http://dx.doi.org/10.3201/ eid0811.020125.
6. Ahmed N, Alam M, Rao KR, Kauser F, Kumar NA, Qazi NN, Sangal V, Sharma VD, Das R, Katoch VM, Murthy KJ, Suneetha S, Sharma SK, Sechi LA, Gilman RH, Hasnain SE. 2004. Molecular genotyping of a large, multicentric collection of tubercle bacilli indicates geographical partitioning of strain variation and has implications for global epidemiology of Mycobacterium tuberculosis. J. Clin. Microbiol. 42:3240-3247. http://dx.doi.org/10.1128/JCM.42.7.3240-3247.2004.
7. Ramazanzadeh R, Farnia P, Amirmozafari N, Ghazi F, Ghadertotonchi Z, Kamran J, Mohammadi F, Mirsaedi M, Masjedi M. 2006. Comparison between molecular epidemiology, geographical regions and drug resistance in Mycobacterium tuberculosis strains isolated from Iranian and Afghan patients. Chemotherapy 52:316-320. http://dx.doi.org/10.1159/000095971.
8. WHO. 2008. Policy guidance on TB drug susceptibility testing (DST) of second-line drugs. WHO/HTM/TB/2008392. WHO, Geneva, Switzerland.
9. WHO Geneva/IUATLD Paris. International Union Against Tuberculosis and Lung Disease. 1998. Guidelines for surveillance of drug resistance in tuberculosis. Int. J. Tuberc. Lung Dis. 2:72-89.
10. Somerville W, Thibert L, Schwartzman K, Behr MA. 2005. Extraction of Mycobacterium tuberculosis DNA: a question of containment. J. Clin. Microbiol. 43:2996-2997. http://dx.doi.org/10.1128/JCM.43.6.2996-2997.2005.
11. Kamerbeek J, Schouls L, Kolk A, van Agterveld M, van Soolingen D, Kuijper S, Bunschoten A, Molhuizen H, Shaw R, Goyal M, van Embden J. 1997. Simultaneous detection and strain differentiation of Mycobacterium tuberculosis for diagnosis and epidemiology. J. Clin. Microbiol. 35: 907-914.
12. Dong H, Liu Z, Lv B, Zhang Y, Liu J, Zhao X, Wan K. 2010. Spoligotypes of Mycobacterium tuberculosis from different provinces of China. J. Clin. Microbiol. 48:4102-4106. http://dx.doi.org/10.1128/JCM.00549-10.
13. Liu Q, Yang D, Xu W, Wang J, Lv B, Shao Y, Song H, Li G, Dong H, Wan K, Wang H. 2011. Molecular typing of Mycobacterium tuberculosis isolates circulating in Jiangsu province, China. BMC Infect. Dis. 11:288. http://dx.doi.org/10.1186/1471-2334-11-288.
14. Pang Y, Zhou Y, Zhao B, Liu G, Jiang G, Xia H, Song Y, Shang Y, Wang S, Zhao YL. 2012. Spoligotyping and drug resistance analysis of Mycobacterium tuberculosis strains from national survey in China. PLoS One 7:e32976. http://dx.doi.org/10.1371/journal.pone.0032976.
15. Tanveer M, Hasan Z, Siddiqui AR, Ali A, Kanji A, Ghebremicheal S, Hasan R. 2008. Genotyping and drug resistance patterns of M. tuberculosis strains in Pakistan.BMCInfect. Dis. 8:171. http://dx.doi.org/10.1186/1471-2334-8-171.
16. Ghebremichael S, Groenheit R, Pennhag A, Koivula T, Andersson E, Bruchfeld J, Hoffner S, Romanus V, Kallenius G. 2010. Drug resistant Mycobacterium tuberculosis of the Beijing genotype does not spread in Sweden. PLoS One 5:e10893. http://dx.doi.org/10.1371/journal.pone.0010893.
17. Wang J, Liu Y, Zhang CL, Ji BY, Zhang LZ, Shao YZ, Jiang SL, Suzuki Y, Nakajima C, Fan CL, Ma YP, Tian GW, Hattori T, Ling H. 2011. Genotypes and characteristics of clustering and drug susceptibility of Mycobacterium tuberculosis isolates collected in Heilongjiang Province, China. J. Clin. Microbiol. 49:1354-1362. http://dx.doi.org/10.1128/JCM.02274-10.
18. Alonso M, Alonso Rodriguez N, Garzelli C, Martinez Lirola M, Herranz M, Samper S, Ruiz Serrano MJ, Bouza E, Garcia de Viedma D. 2010. Characterization of Mycobacterium tuberculosis Beijing isolates from the Mediterranean area. BMC Microbiol. 10:151. http://dx.doi.org/10.1186/1471-2180-10-151.
19. Yuan X, Zhang T, Kawakami K, Zhu J, Li H, Lei J, Tu S. 2012. Molecular characterization of multidrug-And extensively drug-resistant Mycobacte-rium tuberculosis strains in Jiangxi, China. J. Clin. Microbiol. 50:2404-2413. http://dx.doi.org/10.1128/JCM.06860-11.
20. Tang K, Sun H, Zhao Y, Guo J, Zhang C, Feng Q, He Y, Luo M, Li Y, Sun Q. 2013. Characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Sichuan in China. Tuberculosis (Edinb) 93:89-95. http://dx.doi.org/10.1016/j.tube.2012.10.009.
21. Yue J, Shi W, Xie J, Li Y, Zeng E, Wang H. 2003. Mutations in the rpoB gene of multidrug-resistant Mycobacterium tuberculosis isolates from China. J. Clin. Microbiol. 41:2209-2212. http://dx.doi.org/10.1128/JCM.41.5.2209-2212. 2003.
22. Zhao LL, Chen Y, Liu HC, Xia Q, Wu XC, Sun Q, Zhao XQ, Li GL, Liu ZG, Wan KL. 2014. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolates from China. Antimicrob. Agents Chemother. 58:1997-2005. http://dx.doi.org/10.1128/AAC.01792-13.
23. Yu XL, Wen ZL, Chen GZ, Li R, Ding BB, Yao YF, Li Y, Wu H, Guo XK, Wang HH, Zhang SL. 11 December 2013. Molecular characterization of multidrug-resistant Mycobacterium tuberculosis isolated from Southcentral in China. J. Antibiot. (Tokyo) http://dx.doi.org/10.1038/ja.2013.133.
24. Luo T, Zhao M, Li X, Xu P, Gui X, Pickerill S, DeRiemer K, Mei J, Gao Q. 2010. Selection of mutations to detect multidrug-resistant Mycobacterium tuberculosis strains in Shanghai, China. Antimicrob. Agents Chemother. 54:1075-1081. http://dx.doi.org/10.1128/AAC.00964-09.
25. Chan RC, Hui M, Chan EW, Au TK, Chin ML, Yip CK, AuYeang CK, Yeung CY, Kam KM, Yip PC, Cheng AF. 2007. Genetic and phenotypic characterization of drug-resistant Mycobacterium tuberculosis isolates in Hong Kong. J. Antimicrob. Chemother. 59:866-873. http://dx.doi.org/10.1093/jac/dkm054.
26. Zhu C, Zhang Y, Shen Y, Siu GK, Wu W, Qian X, Deng G, Xu Y, Lau R, Fan X, Zhang W, Lu H, Yam WC. 2012. Molecular characterization of fluoroquinolone- resistant Mycobacterium tuberculosis clinical isolates from Shanghai, China. Diagn. Microbiol. Infect. Dis. 73:260-263. http://dx.doi.org/10.1016/j. diagmicrobio.2012.03.025.
27. Campbell PJ, Morlock GP, Sikes RD, Dalton TL, Metchock B, Starks AM, Hooks DP, Cowan LS, Plikaytis BB, Posey JE. 2011. Molecular detection of mutations associated with first-And second-line drug resistance compared with conventional drug susceptibility testing of Mycobacterium tuberculosis. Antimicrob. Agents Chemother. 55:2032-2041. http://dx.doi.org/10.1128/AAC.01550- 10.
28. Jnawali HN, Hwang SC, Park YK, Kim H, Lee YS, Chung GT, Choe KH, Ryoo S. 2013. Characterization of mutations in multi-And extensive drug resistance among strains of Mycobacterium tuberculosis clinical isolates in Republic of Korea. Diagn. Microbiol. Infect. Dis. 76:187-196. http://dx.doi.org/10.1016/j. diagmicrobio.2013.02.035.
29. Du Q, Dai G, Long Q, Yu X, Dong L, Huang H, Xie J. 2013. Mycobacterium tuberculosis rrs A1401G mutation correlates with high-level resistance to kanamycin, amikacin, and capreomycin in clinical isolates from mainland China. Diagn. Microbiol. Infect. Dis. 77:138-142. http://dx.doi.org/10.1016/j. diagmicrobio.2013.06.031.
30. Hu Y, Hoffner S, Wu L, Zhao Q, Jiang W, Xu B. 2013. Prevalence and genetic characterization of second-line drug-resistant and extensively drug-resistant Mycobacterium tuberculosis in rural China. Antimicrob. Agents Chemother. 57:3857-3863. http://dx.doi.org/10.1128/AAC.00102-13.
31. da Silva PE, Von Groll A, Martin A, Palomino JC. 2011. Efflux as a mechanism for drug resistance in Mycobacterium tuberculosis. FEMS Immunol. Med. Microbiol. 63:1-9. http://dx.doi.org/10.1111/j.1574-695X.2011.00831.x.
32. Baldeviano-Vidalón GC, Quispe-Torres N, Bonilla-Asalde C, Gastiaburú-Rodriguez D, Pro-Cuba JE, Llanos-Zavalaga F. 2005. Multiple infection with resistant and sensitive M. tuberculosis strains during treatment of pulmonary tuberculosis patients. Int. J. Tuberc. Lung Dis. 9:1155-1160.
33. Almeida Da Silva PE, Palomino JC. 2011. Molecular basis and mechanisms of drug resistance in Mycobacterium tuberculosis: classical and new drugs. J. Antimicrob. Chemother. 66:1417-1430. http://dx.doi.org/10.1093/jac/dkr173.
34. Barco P, Cardoso RF, Hirata RD, Leite CQ, Pandolfi JR, Sato DN, Shikama ML, de Melo FF, Mamizuka EM, Campanerut PA, Hirata MH. 2006. pncA mutations in pyrazinamide-resistant Mycobacterium tuberculosis clinical isolates from the southeast region of Brazil. J. Antimicrob. Chemother. 58:930-935. http://dx.doi.org/10.1093/jac/dkl363.
35. Mphahlele M, Syre H, Valvatne H, Stavrum R, Mannsaker T, Muthivhi T, Weyer K, Fourie PB, Grewal HM. 2008. Pyrazinamide resistance among South African multidrug-resistant Mycobacterium tuberculosis isolates. J. Clin. Microbiol. 46:3459-3464. http://dx.doi.org/10.1128/JCM.00973-08.